» Articles » PMID: 29229929

Oestrogen Receptor-α Binds the FOXP3 Promoter and Modulates Regulatory T-cell Function in Human Cervical Cancer

Overview
Journal Sci Rep
Specialty Science
Date 2017 Dec 13
PMID 29229929
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Oestrogen controls Foxp3 expression in regulatory T cells (T cells) via a mechanism thought to involve oestrogen receptor alpha (ERα), but the molecular basis and functional impact of ERα signalling in T cells remain unclear. We report that ERα ligand oestradiol (E2) is significantly increased in human cervical cancer (CxCa) tissues and tumour-infiltrating T cells (CD4CD25CD127), whereas blocking ERα with the antagonist ICI 182,780 abolishes FOXP3 expression and impairs the function of CxCa infiltrating T cells. Using a novel approach of co-immunoprecipitation with antibodies to E2 for capture, we identified binding of E2:ERα complexes to FOXP3 protein in CxCa-derived T cells. Chromatin immunoprecipitation analyses of male blood T cells revealed ERα occupancy at the FOXP3 promoter and conserved non-coding DNA elements 2 and 3. Accordingly, computational analyses of the enriched regions uncovered eight putative oestrogen response elements predicted to form a loop that can activate the FOXP3 promoter. Together, these data suggest that E2-mediated ERα signalling is critical for the sustenance of FOXP3 expression and T cell function in human CxCa via direct interaction of ERα with FOXP3 promoter. Overall, our work gives a molecular insight into ERα signalling and highlights a fundamental role of E2 in controlling human T cell physiology.

Citing Articles

Mendelian randomization study identifying immune cell phenotypes associated with breast cancer risk.

Zhang Z, Zhao J, Li Y, Zhang H, Chen Y, Yang L Discov Oncol. 2025; 16(1):205.

PMID: 39969618 PMC: 11839965. DOI: 10.1007/s12672-025-01963-z.


Regulation of Stromal Cells by Sex Steroid Hormones in the Breast Cancer Microenvironment.

Yamaguchi-Tanaka M, Takagi K, Sato A, Yamazaki Y, Miyashita M, Masamune A Cancers (Basel). 2024; 16(23).

PMID: 39682229 PMC: 11639972. DOI: 10.3390/cancers16234043.


FOXP3 splice variant expression in males and females in healthy populations and in kidney transplant recipients.

Saleh Q, Mohammadnejad A, Tepel M Sci Rep. 2024; 14(1):12112.

PMID: 38802392 PMC: 11130272. DOI: 10.1038/s41598-024-62149-1.


Regulatory T cell-derived enkephalin gates nociception.

Midavaine E, Moraes B, Benitez J, Rodriguez S, Braz J, Kochhar N bioRxiv. 2024; .

PMID: 38798460 PMC: 11118376. DOI: 10.1101/2024.05.11.593442.


Indole-3-acetic acid alleviates DSS-induced colitis by promoting the production of R-equol from .

Li M, Han X, Sun L, Liu X, Zhang W, Hao J Gut Microbes. 2024; 16(1):2329147.

PMID: 38528729 PMC: 10968315. DOI: 10.1080/19490976.2024.2329147.


References
1.
Sekiya T, Kashiwagi I, Inoue N, Morita R, Hori S, Waldmann H . The nuclear orphan receptor Nr4a2 induces Foxp3 and regulates differentiation of CD4+ T cells. Nat Commun. 2011; 2:269. PMC: 3104557. DOI: 10.1038/ncomms1272. View

2.
Filaci G, Fenoglio D, Fravega M, Ansaldo G, Borgonovo G, Traverso P . CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers. J Immunol. 2007; 179(7):4323-34. DOI: 10.4049/jimmunol.179.7.4323. View

3.
Luo C, Wang L, Sun C, Li D . Estrogen enhances the functions of CD4(+)CD25(+)Foxp3(+) regulatory T cells that suppress osteoclast differentiation and bone resorption in vitro. Cell Mol Immunol. 2011; 8(1):50-8. PMC: 4002989. DOI: 10.1038/cmi.2010.54. View

4.
Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z . Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev. 2006; 212:8-27. DOI: 10.1111/j.0105-2896.2006.00427.x. View

5.
Yates M, Li Y, Chlebeck P, Offner H . GPR30, but not estrogen receptor-alpha, is crucial in the treatment of experimental autoimmune encephalomyelitis by oral ethinyl estradiol. BMC Immunol. 2010; 11:20. PMC: 2864220. DOI: 10.1186/1471-2172-11-20. View